MinkowskiO: Historical development of the theory of pancreatic diabetes. Introduction and translation by R. Levine. Diabetes, 38:1–6, 1989.
2.
BantingFGBestCHCollipJB,: Pancreatic extracts in the treatment of diabetes mellitusCan Med Assoc J12:141–146, 1922.
3.
BlissM: The Discovery of Insulin. Chicago, IL, University of Chicago Press, 1982.
4.
KahnCRShechterY: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas, in GilmanAFRallTWNiesAS (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed.New York, NY, Pergamon Press, 1990, p 1464.
5.
OrciL: The insulin cell; its cellular environment and how it processes (pro)insulinDiabetes Metab Rev2:71–106, 1986.
6.
PolonskyKSRubensteinAH: Current approaches to measurement of insulin secretionDiabetes Metab Rev2:315–329, 1986.
7.
MeglassonMDMatschinskyFM: Pancreatic islet glucose metabolism and regulation of insulin secretionDiabetes Metab Rev2:163–214, 1986.
8.
PorteDJrHalterJB: The endocrine pancreas and diabetes mellitus, in WilliamsRH (ed): Textbook of Endocrinology, 6th ed.Philadelphia, PA, Saunders Co, 1981, pp 716–843.
9.
ShimazuTIshikawaK: Modulation by the hypothalamus of glucagon and insulin secretion in rabbits; studies with electrical and chemical stimulationsEndocrinology108:605–611, 1981.
10.
MeglassonMDMatschinskyFM: Pancreatic islet glucose metabolism and regulation of insulin secretionDiabetes Metab Rev2:163–214, 1986.
11.
SchadeDSEatonRP: Diabetic ketoacidosis—pathogenesis, prevention and therapyClin Endocrinol Metab12:321–338, 1983.
12.
SodoyezJCSodoyez-GoffauxFGuillaumeM,: 123I-insulin metabolism in normal rats and humans: External detection by a scintillation cameraScience2:865–868, 1983.
13.
DuckworthWC: Insulin degradation: Mechanisms, products and significanceEndocrinol Rev9:319–345, 1988.
14.
RabkinRRyanMPDuckworthWC: The renal metabolism of insulinDiabetologia27:351–357, 1984.
15.
KahnCRShechterY: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas, in GilmanAGRallTWNiesASTaylorP (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, eighth ed.New York, NY, Pergamon Press, 1990, p 1468.
16.
KahnCRWhiteMF: The insulin receptor and the molecular mechanism of insulin actionJ Clin Invest82:1151–1156, 1988.
17.
KasugaMKarlssonFAKahnCR: Insulin stimulates the phosphorylation of the 95,000 dalton sub-unit of its own receptorScience215:185–187, 1982.
18.
RosenOM: After insulin bindsScience237:1452–1458, 1987.
19.
KahnCRWhiteMF: The insulin receptor and the molecular mechanism of insulin actionJ Clin Invest82:1151–1156, 1988.
EllisLClauserEMorganDO,: Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin stimulated kinase activity and uptake of 2-deoxy glucoseCell45:721–732, 1986.
22.
ChouCKDullTJRussellDS,: Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulinJ Biol Chem262:1842–1847, 1987.
23.
SuzukiKKonoT: Evidence that insulin causes translocation of glucose transport activity of the plasma membrane from an intracellular storage siteProc Natl Acad Sci USA77:2542–2545, 1980.
24.
SimpsonIACushmanSW: Hormonal regulation of mammalian glucose transportAnn Rev Biochem55:1059–1089, 1986.
25.
JamesDEBrownRNavarroJ,: Insulin regulatable tissues express a unique insulin-sensitive glucose transport proteinNature333:183–185, 1988.
26.
GarveyWTHucksteadtTPBirnbaumMJ: Pretranslational suppression of an insulin responsive glucose transporter in rats with diabetes mellitusScience245:60–63, 1989.
27.
TaskinenMR: Lipoprotein lipase in diabetesDiabetes Metab Rev3:551–570, 1987.
28.
KahnCRShechterY: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas, in GilmanAFRallTWNiesASTaylorP (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed.New York, NY, Pergamon Press, 1990, pp 1473–1474.
29.
GallowayJA: Insulin treatment for the early 80's: Facts and questions about old and new insulins and their usageDiabetes Care3:615–622, 1980.
30.
DeckenT: Intermediate-acting insulin preparations: NPH and lenteDiabetes Care3:623–626, 1980.
31.
FranciscoGE: Diabetes mellitus, in DiPiroJTTalbertRHayesPYeeG (eds): Pharmacotherapy, A Pathophysiologic Approach. New York, NY, Elsevier, 1989.
32.
HomePDAlbertiKGMM: The new insulins: Their characteristics and clinical indicationsDrugs24:401–413, 1982.
33.
DeckertT: Intermediate-acting insulin preparations: NPH and lenteDiabetes Care3:623–626, 1980.
34.
SkylerJS: Insulin pharmacologyMed Clin North Am72:1337–1354, 1988.
35.
KahnCRShechterY: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas, in GilmanAFRallTWNiesASTaylorP (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed.New York, NY, Pergamon Press, 1990, p 1475.
36.
FrazierLMMulrowCDAlexanderLT,: Need for insulin therapy in type II diabetes mellitus: A randomized trialArch Intern Med147:1085–1089, 1987.
37.
SkylerJS: Insulin pharmacologyMed Clin North Am72:1337–1354, 1988.
38.
KahnCRShechterY: Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas, in GilmanAFRallTWNiesASTaylorP (eds): Goodman and Gilman, The Pharmacologic Basis of Therapeutics, eighth ed.New York, NY, Pergamon Press, 1990, p 1477.
39.
Position Statement: Insulin Administration. Diabetes Care14:30–33, 1991 (suppl 2).
40.
GallowayJASpradlinCTNelsonRL,: Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixturesDiabetes Care4:366–376, 1981.
41.
American Diabetes Association: The Physician's Guide to Type II Diabetes (NIDDM): Diagnosis and Treatment. New York, NY, American Diabetes Association, 1984, pp 1–112.
42.
GregermanRI: Diabetes mellitus, in BarkerLRBurtonJRZievePD (eds): Principles of Ambulatory Medicine. Baltimore, MD, Williams and Wilkins, 1986, pp 951–986.
American Diabetes Association: The Physician's Guide to Type II Diabetes (NIDDM): Diagnosis and Treatment. New York, NY, American Diabetes Association, 1984, pp 1–112.
45.
WilsonRMClarkePBarkesH,: Starting insulin treatment as an outpatient: Report of 100 consecutive patients followed up for at least one yearJAMA256:877–880, 1986.
46.
GregermanRI: Diabetes mellitus, in BarkerLRBurtonJRZievePD (eds): Principles of Ambulatory Medicine. Baltimore, MD, Williams and Wilkins, 1986, pp 951–986.
47.
CryerPEGerichJE: Glucose counterregulation, hypoglycemia and intensive insulin therapy in diabetes mellitusN Engl J Med313:232–241, 1985.
48.
HeineRJ,: Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulinsDiabetologia27:558–562, 1984.
49.
OlssonP-OHansAHenningVS: Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulinDiabetes Care10:473–477, 1987.
50.
BestJDLeyCJStraussBJG,: Clinical effects of mixing short- and intermediate-acting insulins in treatment of non-insulin-dependent diabetesMed J Aust146:621–627, 1987.
51.
Drug Evaluations Annual1992, American Medical Association, Chicago, IL.
52.
AdamsPSHaines-NuttRFTownR: Stability of insulin mixtures in disposable plastic insulin syringesJ Pharm Pharmacol39:158–163, 1987.
53.
PetersALDavidsonMB: Effect of storage on action of NPH and regular insulin mixturesDiabetes Care10:799–800, 1987.
54.
JawadiMHHoLS: Stability and reproducibility of biologic activity of premixed and short-acting and intermediate-acting insulinsAm J Med81:467–471, 1986.
55.
AhrensERGossainVVRovnerDR: Human insulin: Its development and clinical usePostgrad Med80:181–187, 1986.
56.
Antidiabetic agents, in American Hospital Formulary Service Drug Information 86, Bethesda, American Society of Hospital Pharmacists, 1984, pp 1562–1594.
57.
GallowayJA: Insulin treatment for the early 80's: Facts and questions about old and new insulins and their usageDiabetes Care3:615–622, 1980.
58.
SkylerJS: Plethora of insulins, editorialDiabetes Care3:638–639, 1980.
59.
SonnenbergGEBergerM: Human insulin: Much ado about one amino acid?Editorial Diabetologia25:457–459, 1983.
60.
HepburnDAFrierBM: Hypoglycemic unawareness and human insulin. Lancet June 17, 1989 (letter) 1393.
61.
MulhauserIHeinemannLFritscheE,: Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparationsDiabetes Care14:745–749, 1991.
62.
ClarkeWLGonder-FrederickLARichardsFE,: Multifactorial origin of hypoglycemic symptom unawareness in IDDMDiabetes40:680–685, 1991.
63.
KernWLiebKKernerW,: Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humansDiabetes39:1091–1095, 1990.
64.
JellinJM (ed): Pharm Letter6:34, 1990.
65.
JellinJM (ed): Pharm Letter5:41, 1989.
66.
JellinJM: Pharm Letter7:60, 1991.
67.
Point Study Group: One-year trial of a remote-controlled implantable insulin infusion system in type I diabetic patients. Lancet2:866–869, 1988.
68.
HalleJ-PLambertJLindmeyerI,: Twice-daily mixed regular and NPH insulin injections with new jet injector versus conventional syringes: Pharmacokinetics of insulin absorptionDiabetes Care9:279–282, 1986.
69.
MaloneJILewittSGroveWP,: Comparison of insulin levels after injection by jet stream and disposable insulin syringeDiabetes Care9:637–640, 1986.
70.
EdsbergB,: Sprinkler needle spreads insulin load for diabetic patientsBr Med J294:1373–1376, 1987.
71.
American Diabetes Association Task force: Position statement on jet injectors. Diabetes Care11:600–601, 1988.
72.
SalzmanRMansonJEGriffingGT,: Intranasal aerosolized insulin: Mixed-meal studies and long-term use in type I diabetesN Engl J Med312:1078–1084, 1985.
AlejandroRNoelJLatifZ,: Human islet cell transplantation: University of Miami School of Medicine experience, in BrunettiPWaldhauslWK (eds): Advanced Models for the Therapy of Insulin-Dependent Diabetes. New York, NY, Raven Press, 1987.
75.
PfeifferEF: On the way to the automated (blood) glucose regulation in diabetes: The dark past, the grey present, the rosy futureDiabetologia30:51–65, 1987.
76.
FranciscoGE: Diabetes mellitus, in DiPiroJTTalbertRHayesPYeeG (eds): Pharmacotherapy, A Pathophysiologic Approach. New York, NY, Elsevier, 1989 p 815.